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Platelet agonists and subendothelial extracellular matrix (ECM) induce morphological and
bio~h~mical changes in animal megakaryocytes,
rem1n1scent of the response of platelets to the
same substances. Wehave examined the behavior of
humanmegakaryocytes exposed for up to 36 hours
to the ECM produced by cultured bovine corneal
endothelial cells. By phase contrast and scanning
electron microscopy these megakaryocytes demonstrated non-reversible adherence and flattening
with formation of long filopodia,
thus confirming
that human megakaryocytes acquire platelet functional capacities.
In addition, megakaryocyte
fragmentation into prospective
platelets
was
apparently induced by the ECM. Up to 50%of the
adherent megakaryocytes underwent spontaneous
fragmentation into small particles
which individually reacted like platelets on the ECM.The
interaction of the megakaryocytes with the ECM
was specific since no adherence, flattening or
fragmentation occured upon incubation of the megakaryocytes on regular tissue culture plastic or
glutaraldehyde fixed ECM. Thus we have demonstrated platelet
like behaviour of humanmegakaryocytes in response to this physiological
basement membraneand a possible role of the subendothelium in platelet production which may occur
in vivo as megakaryocytes cross the sinusoid walls
and enter the blood stream.
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Megakaryocytes synthesize and assemble platelet components and organelles.
They acquire many
platelet properties and respond to knownplatelet
agonists such as ADP, thrombin and arachidonic
acid with shape change, degranulation and reversible flattening reaction (3,6,15-17,20-22,25,28).
Unlike platelets, however, they do not adhere to
nor demonstrate these morphological changes upon
exposure to collagen coated surfaces (15,17). We
have recently shown that guinea pig and rat megakaryocytes can be activated by interaction with an
extracellular matrix (ECM) produced by cultured
endothelial cells (18). This activation was associated with irreversible
adhesion and spreading,
with the formation of long filopodia and with the
release of thromboxane A2 (18).
The ECM produced by cultured endothelial
cells (bovine or human) closely resembles the
vascular subendothelial basement membranein it's
supramolecular structure and chemical composition
(9,27). It contains characteristic components of
basement membranessuch as types IV and V collagen, laminin, fibronectin
and heparan sulfate
(14,27,32). In addition the ECMhas been shown to
contain collagen types I and III, dermatan sulfate
and chondroitin sulfate proteoglycans and elastin.
Wehave previously reported on the use of this
matrix as a model to study the interaction between
platelets and the vascular subendothelium (5,32).
Previous work by others has made clear the functional equivalence of bovine or humanECMand
vessel wall
subendothelium from rabbits and
humans, and the generic nature of the interaction
with it by platelets
of various species (27). The
uniformity, transparency and obvious biological
relevance of this in vitro generated ECMmake it a
good model with which to study cell surface interactions important in hemostasis.
In the present study we extend our observations to human megakaryocytes, isolated from
bone marrow specimens by centrifugal counterflow
elutriation and a continuous Percoll density gradient. Our results demonstrate that humanmegakaryocytes respond to the stimulus of ECMby
adhesion and shape change. Wehave also shown the
spontaneous fragmentation of megakaryocytes on the
ECMto form platelet like structures.
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Methods and Materials
Preparation of ECMcoated Plates:
Cultures of bovine corneal endothelial cells
were established as described previously {7,9,32).
Stock cultures were maintained in Dulbecco's
modified Eagle's medium (DMEM,
H-16) supplemented
with 5% calf serum, 10% fetal calf serum and
Gentamycin (50 ug/ml) (all from Grand Island
Biological Co., Grand Island, NY) at 37oc in a 10%
CO2 humidified incubator. Cells were passaged
weekly at a split ratio of 1:64 and fibroblast
growth factor (100 ng/ml) was added on alternate
days during the phase of active cell growth. The
fibroblast growth factor was purified from bovine
brain as described previously (8). For preparation
of ECMcoated surfaces, cells were plated at an
initial
density of 4xlo4 cells per 35mmdish
(Falcon Inc., Oxnard, CA) and 4% Dextran T-40
(Pharmacia, Sweden) was included in the growth
medium. Six to eight days after reaching confluency the cell layer was dissolved by a 3 minute
exposure to 0.5% (v/v)
Triton X-100 (Sigma
Chemicals Co., St Louis, Mo) and 0.025N NH40Hin
phosphate buffered saline (PBS) pH 7.3 at 220c,
followed by 4 washes in PBS. This treatment left
the underlying ECMintact,
firmly attached to the
entire area of the tissue culture dish and free of
any cellular debris as determined by SEM(9,10).
Someof the ECM coated dishes were the kind gift
of
International
Biotechnologies,
Hadassah,
Jerusalem.
Megakaryocyte Isolation:
Humanbone marrow was obtained from the waste
material of bone removed during orthopedic operations. Bone marrow tissue was collected into
calcium and magnesiumfree Hank's Basic Salt Solution (HBSS)(Grand Island Biological Co., Grand
Island, NY) containing 3.8% sodium citrate, lo-3M
adenosine and 2x10-3M theophylline (all Sigma
Chemicals Co., St Louis, Mo) (CATCH
medium) (16,17). Single cell suspensions were made by repeatedly pipetting the material through a sterile,
siliconized pasteur pipette,
and then filtering
the suspended material through a 150 mesh sieve.
The resultant suspension was sedimented by centrifugation at 400g for 8-10 minutes, and the pellet
was resuspended in the same "CATCH"
medium. This
proceedure was repeated twice. The final pellet
was resuspended in "CATCH"medium and was then
enriched by centrifugal,
counterflow elutriation
in a Beckman J2-21 centrifuge (BeckmanInstruments, Palo Alto, Ca) using the JE-6 elutriation
rotor at 2500rpm (2,23). The separation chamber
was then removed and the pellet was resuspended in
calcium and magnesium free HBSS,and passed once
again through a 150 mesh sieve. This suspension
was centrifuged at 400g for 10 minutes, and the
cells resuspended in the same solution, at a cell
density of 2-3xl0 6 cells/ml.
For a further separation we developed a continuous Percoll density
gradient, self generated around a median density
of 1.057 gm/ml. The Percoll solution (Pharmacia,
Sweden) was made up with HBSS(Ca++ and Mg++free)
to the correct density. The pH was corrected (when
necessary) with lN NaOH or HCl to 7.35-7.45, and
the osmolarity was corrected to 290-295mosm/lwith
distilled water or HBSS xlO, as necessary. The
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final solution
was sterilized
by filtration
through a 0.22um filter
(FP 030/3, Schleicher and
Schuell, W. Germany). The solution was placed in
polycarbonate bottles (Beckman, USA)and density
marker beads (0.05-0.075ml each of numbers 1-7,
Pharmacia, Sweden) were added to the standard. The
gradient was generated at 20000g, for 30 minutes
at 5°c in a Sorvall RC-5 centrifuge with the SM-24
rotor (Sorvall, Norwalk, Conn.). The cell suspension was layered upon the density gradient and
centrifuged at 800g for 20 minutes (20°c). The
layers of a density 1.015-1.045 gm/ml were gently
removed, utilizing the standard as a guide. The
layers 1.045-l.055gm/ml were also removed, giving
a lower purity but a higher yield of young, immature forms. The fractions thus obtained were
washed in HBSS3 times until free of Percoll. The
final fractions contained a total of 3-7x105 megakaryocytes, with a purity of 60-80% in the lighter
fractions, which were mainly large, mature forms.
The heavier fractions
(1.045-1.055 gm/ml) contained 1-2x105 megakaryocytes with a purity of 3040%mainly of the smaller immature forms.
Megakaryocyte reactivity with ECM:
Isolated megakaryocytes were incubated with
Dulbecco's MEM
H-16 with 2.3% bovine serum albumin
(Miles Laboratories, Kankakee, Il) and with penicillin (50 units/ml) and streptomycin (50ug/ml)
(Grand Island Biological Co., Grand Island, NY)
(3). Most cultures were performed at 0.5-lxlo5
megakaryocytes/ml of medium, and sometimes as high
as 2.5x105/ml. They were kept at 37oc in suspension for one hour to enable the megakaryocytes to
"recover" from the repeated centrifugations and
washings. The cell suspensions were then added to
ECMcoated dishes previously placed in the incubator to minimize agitation during the seeding of
the megakaryocytes. Contra 1 experiments were
carried out in tissue culture dishes of the same
manufacture which were not coated with ECM,or in
ECMcoated dishes fixed with 1%glutaraldehyde for
1 hour. Incubations were carried out for up to 36
hours in a humidified incubator at 37°c, in 10%
co2 in air. These conditions maintained a stable
pH of 7.2-7.3 for the duration of the experiment.
Morphological studies:
Cells in culture were examined in situ with
an Olympusinverted phase microscope, at 100-400x.
Culture dishes (35mm) were prepared for scanning
electron microscopy (SEM) by tilting the dishes,
gently aspirating the culture medium and then
slowly dripping 1ml of warm (37°C) phosphate
buffered (pH7.3) 2.5% glutaraldehyde solution down
the side of the dish. After fixation they were
prepared for scanning by the GTGO
method and air
drying as previously described (32). The samples
were gold-palladium sputter coated in situ and the
entire 35mmdish was examined, using a specially
constructed holder that was inserted into the
specimen chamber of the JEOL JSM 35 scanning
electron microscope.
Megakaryocyte adhesion:
In order to determine whether megakaryocytes
on the ECMwere firmly adherent to the surface or
were merely resting there without attachment we
used a simple test for adhesiveness, as described
by Levine et al (18). At various intervals after
seeding, the number of megakaryocytes per field
was counted by phase contrast microscopy in five
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fields in the central portion of each dish at
200x. The dishes were tilted to 45o three times in
three seconds; following the third time the dish
was kept at that angle and the mediumwas gently
aspirated. A similar five fields were immediately
counted. The megakaryocytes remaining attached to
the ECMafter this relatively reproducible force
were judged to have become adherent and the percentage of adherence was calculated as the ratio
of the second count to the first for each dish.
Results
Mor holo ical a earance of me akar oc tes seeded
astic non-coated surfaces:
Human megakaryocytes, upon incubation in
tissue culture
plastic vessels without ECM,
retained the spherical shape and irregular surface
characteristic of these cells (Fig.1) (4,12,16,24). Similar to our observations with guinea pig
and rat megakaryocytes (18) this shape was maintained usually throughout the 36 hour period of
incubation, without evidence of adhesion, flattening or fragmentation. To prepare the dishes for
SEMwithout losing the cells, it was necessary to
use care in removing the medium, as the slightest
agitation of the fluid caused the cells to float
off and be removed during the aspirations. In
addition megakaryocytes did not adhere to, nor
flatten, when seeded upon glutaraldehyde treated
ECM.
Morphological
appearance
of megakaryocytes
plated upon ECMcoated surfaces:
Humanmegakaryocytes demonstrated rapid adhesion to ECMcoated dishes. As the sedimentation
rate of megakaryocytes is greater than lmm/min
(16) and the depth of the mediumwas approximately
2-3mm, the cells came into contact with the ECM
within 2-3 minutes of placement upon the matrix.
The adherence test described above was performed
on identical
samples (from the same batch) at
various times ranging from 10 minutes to 36 hours
after seeding the cells. Within 10 minutes 50%or
more of the megakaryocytes adhered. Manyof them
also promptly demonstrated fine tenuous filopodia
(Fig.2) or, in some cells, a concentric flattening
to a broad spreading veil of cytoplasm, from the
margins of which fine filopodia arose. By 30
minutes post seeding, over 75%of megakaryocytes
had become adherent and the filopodia became more
pronounced and thicker.
Somemegakaryocytes flattened so completely by this time that only a few
bumps were observed protruding from the surface
due to the large nuclear lobes beneath them
(Fig.3). These flattened cells often had a total
diameter of over 30µm, with mature filopodia
extending from the cell periphery. After 12 hours
of incubation, individual
cells developed no
further flattening
or formation of filopodia.
Beyondthis time spontaneous fragmentation began
to occur. Megakaryocyte cytoplasm dispersed into a
network of globules
interlocked by filopodia
(Fig.4). The fragmented cytoplasm of each cell was
spread out in an oval shape with a diameter of 70lSOµm along the long axis, and when enlarged
clearly showed the fine connections between the
platelet like fragments (Fig. 5). Each of these
fragments had a diameter of 2-12µm. They demonstrated platelet like morphological changes,
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Figure 1: SEMof humanmegakarocytes incubated on
tissue culture dish. Figure 2: Humanmegakaryocyte, 10 minutes on ECM, demonstrating initial
formation of fine filopodia. Figure 3: Humanmegakaryocyte, 30 minutes on ECM. Note that the cell
has already flattened noticeably, forming a spreading veil of cytoplasm in contact with the ECM.
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adhering to the ECMand forming filopodia of their
own (Fig.6), similar to those observed with human
and animal platelets
incubated on ECM(Fig.7).
An occasional cell seemed to be spewing out young
platelets from within (Fig.8). By the end of 36
hours of incubation, approximately 50% of the
cells were found to have undergone fragmentation,
25%had flattened with peripheral filopodia and a
further 25%remained round and non-adherent. The
latter consisted primarily of dying and dead cells
as shown by the trypan blue exclusion test. This
proportion is
consistent
with our previous
observations on cell mortality during incubation
(16, 18).
Discussion
Possession of platelet
functional capacities by
megakaryocytes was first
demonstrated by Levine
and Fedorko (16). Numerousstudies since then have
shown platelet-like
responses to various soluble
agoni sts (ADP etc')
(15, 22). In a recent study
(18) we showed a marked similarity between the
morphological and secretory response of guinea-pig
and rat platelets
and megakaryocytes to subendothelium. Here, we extend these observations for
the first time to humanmegakaryocytes.In common
with platelets,
humanmegakaryocytes demonstrated
classical platelet
adhesion, filopodia formation
and spreading upon contact with the ECM.The megakaryocytes became attached to the ECMwithin 10-30
minutes, immediately lost their irregular surface
appearance and started to form filopodia and fine
cytomembranousextensions towards the ECM.Some
megakaryocytes progressively flattened, sometimes
to the point of becoming thin and "pancake"-like
in form, with just a bumpwhere the nucleus was to
be found. These morphological changes were dependent upon the presence of the ECM. In other
experiments, guinea pig megakaryocytes cultured
upon plastic tissue culture dishes, or plastic
surfaces coated with fibronectin, types I,II,III
and IV collagen (15,22) laminin or glutaraldehyde
fixed ECM (unpublished observations), displayed
neither adhesion nor shape changes. The typical
activation of megakaryocytes by the ECMindicates
that at least several components of the basal
lamina are needed to elicit
the responses of adhesion, shape change and release. Indeed, Leven
and Nachmias showed that when a surface coated
with collagen (type I,II,III
or IV) had fibronectin added to it, megakaryocyte flattening was
induced, but not the other morphological changes
(15). While collagen type IV, laminin and fibronectin are major components of the ECM,it is
possible that other matrix components, the relative proportions of the various constituents and/
or the tertiary
structure of this naturally produced basement membrane are involved in adhesion,
flattening and in the development of multiple,
radial long filopodia.
The latter possibility is
also suggested by· the lack of response of megakaryocytes to contact with glutaraldehyde fixed
ECM.Similarly to platelets,
the typical shape
change of megakaryocytes has been shown to be
associated with activation of contractile proteins
(6,15,22). As this study would suggest, the platelet forming process may differ and not be related,
that is not one of "budding off". The observation
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of fragmentation of half of the megakaryocytes
attached to the ECMsuggests that a possible route
to platelet
production by megakaryocytes may be
one of fragmentation, whereby the megakaryocyte
"disintegrates" forming a large number of platelets. In these experiments, platelet-like
fragments have apparently formed but -thanks to the
ECM-have not detached from each other. The myriad
individual small islands of megakaryocyte cytoplasm have attached to the ECMin a manner similar
to that of platelets
from peripheral blood. This
would support the observations of previous authors
(1,11,13,26,29,30,31),
who have also noticed
"fragmentation" or "disintegration" of megakaryocytes. This fragmentation of megakaryocytes was
originally
postulated by Wright in 1906 who
observed the formation of pseudopods and protoplasmic elongations (33), and later observed by
Thiery and Bessis (31) who utilized time lapse
cinematography to show the cells forming long
strands from which they concluded that the platelets are formed. Izak et al placed bone marrow
aspirates in a culture medium for up to six days
and observed the formation of possible platelets
by the megakaryocytes (13). Tavassoli and Shaklai,
along with others believe that the platelet surface membranes are formed from an extensively
invaginated megakaryocyte surface membranecalled
the demarcation membrane system (OMS)(1,17,29,
30). They have suggested that individual platelets
are freed by fusion
of the membranes with
subsequent fission
from adjoining platelets
(29,30). Recently Haller and Radley utilized time
lapse
cinematography and scanning electron
microscopy to study the behaviour of mouse
megakaryocytes in a bone marrow specimen placed
between two glass surfaces (11). They observed the
formation of globules,
linked by strands of
cytoplasm extending pseudopodia towards the glass
surface. They hypothesized that the tubular
invaginations observed by themselves and other
authors served as a membrane reserve for the
attenuated processes and ultimately became the
exterior surface of the newly formed platelets
(11). They preferred
the term "i nvagi nation
membranesystem" instead of "demarcation membrane
system" (11).
Our finding (Figs. 4,8)
that
fragmentation seems to have begun inside the
megakaryocyte would tend to support the views of
Tavassol i and Shaklai (29), Behnke (1) and Levine
(17). Due to technical limitations, (caused by the
dispersion of the fragmented megakaryocytes upon
the ECM)it has not yet been possible to perform
transmission
electron
microscopy on these
fragments to prove conclusively that they are ultrastructurally"true" platelets. Despite this,
their behaviour upon the matrix is, as far as can
be judged upon SEM,
similar to that of washed
platelets from peripheral blood.
Thus the interactions of humanmegakaryocytes
and ECM illustrate
two facets of megakaryocyte
behaviour. One is the aquisition,
even before
platelet shedding, of the functional behavioral
capacity of circulating
platelets,
namely the
adhesion and shape change of megakaryocytes on
ECM. These morphological responses are demonstrated here for the first
time in humanmegakaryocytes. The other is a possible role of ECMas
an anchor or inducer of platelet shedding in vivo,
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Figure 4: Fragmentation of human megakarocyte plated on ECM. Small globules are observed
interlocked by filopodia-like strands.
Figure 5: Fragments of megakaryocytes of different
sizes linked to each other and the ECM by filamentous interconnections.
Figure 6: Adherence
of a megakaryocyte fragment to the ECMby filopodia extending from the platelet-like
fragment.
Figure 7: Platelets from peripheral blood on ECM. Adherence to the matrix is associated with
filopodia formation. Note the resemblance to the fragmented megakaryocytes in terms of the
type of adherence and formation of filopodia.
Figure 8: Humanmegakaryocyte, in the process
of fragmenting. Note the formation of fragments seemingly within the body of the cell, and the
filopodia linking the fragments on the outside.
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Discussion with Reviewers
M. Tavassoli:
Could you give further details
about the elutriation
process.
Why was it
performed prior to the density gradients?
Authors: The elutriation was performed in the JE6 rotor using the original ~eckman chamber. Flow
rates at 2500rpm for human cells were varied
between 18ml/min and 39ml/min in 2-4ml/min
increments with the steps at each 100ml eluted
volume. Elutriation
preceeded the density
gradients because it
removed the mass of
erythrocytes,
platelets
and many of the other
cells, leaving a relatively
small pellet of cells
for final seperation
on the gradient. This
gradient, whilst capable of high purity yields, is
very sensitive to cell load/ gradient volume
ratio.
A large number of loaded cells would
necessitate a very large volume of gradient.

none -if

M. Tavassoli: Fig. 4 is very reminiscent of the
concept of proplatelet
formation that inter alia
has been discussed in ref. 30. The concept
maintains that platelet
formation occurs via
formation of a dozen or so elongated strings of
megakaryocyte cytoplasm, each can then form
several hundred platelets.
Would the authors
commenton this view in the context of their own
findings.
Authors: The term "proplatelets" was discussed by
Dr. Tavassoli in his paper (ref. 30). The concept
of largish chunks of cytoplasm, each equivalent to
the volume of a few lO's - lOO's of platelets
flowing through the blood stream to eventual
fragmentation would not be in conflict with the
observed interaction
described here in a static
system.
In .another
series
of experiments
(Manuscript
in
preperation),
guinea pig
megakaryocytes were placed on ECM in a flow
chamber. After a few hours of exposure to the
flowing medium, elongated strips of cytoplasm were
formed by the flow, later detaching themselves and
were carried downstream. These could be termed
proplatelets.
One must not forget that these
experiments (in the present paper) were static in
nature, and therefore there was no incentive for
the megakaryocytes to form large chunks of
cytoplasm, but were able to proceed to
fragmentation in-situ.

M. Tavassoli:
What was the viability after the
proceedures?
Authors:
)92% viability
by the trypan blue
exclusion method.
M. Tavassoli: Which other cells were in the final
preperation?
Authors:
The major contaminating cells were
eosinophils.
Erythrocytes
and
undefined
mononuclears' were also commonlyfound.
M. Tavassoli:
The authors obtain two fractions
with young and old megakaryocytes. Was there any
difference qualitatively or quantitatively in the
interaction of these two preperations with ECM?
Authors: We made no attempt to quantitate a
difference. This was because the identification of
the cells on the plate (when dealing with immature
cells) was exceedingly difficult,
especially those
of 2-4N and immature cytoplasm. Weknowthat they
were there
from
cytospin
and staining
preparations, but not many seem to have spread,
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M. Tavassoli: This association may explain why in
the marrow megakaryocytes are preferentially
located in the subendothelial region of marrow
sinus endothelium as observed by Lichtman et al.
(ref. 19).
Authors:
Yes, we would certainly concur with
this. If we attribute
"migratory" properties to
the megakaryocytes then they are going to adhere
preferentially
to the subendothelium. Carrying
this one step further we could hypothesize that
this adhesion activates them and then they can
proceed to fragmentation after having been swept
along by the blood stream to the lungs.
J. Breton-Gorius:
Are immature megakaryocytes
able to spread and to give long filopodia? If this
occurs in megakaryoblasts with minimal maturation
this formation of filopodia on ECM does not
correspond to the
long cytoplasmic processes
observed before the platelet
shedding by in vivo
mature megakaryocytes.
Authors: As we commented above, in answer to Dr.
Tavassoli 's question, the identification of young
megakaryocytes on SEM is difficult, but despite
that fairly small megakaryocytes were seen to
adhere and form filopodia.
We would agree that
these filopodia are not the long cytoplasmic
processes from which platelet
shedding occurs,
according to some authors because, as one can see
(fig. 8) there were no marked filopodia nor
spreading as a prerequisite
for fragmentation, a
fact we refer to in our discussion about platelet
formation.
J. Breton-Gorius: Leven & Nachmias (text ref. 15)
showed that the flattening of megakaryocytes was

VGCaine, I Vlodavsky, M Hersh et al.
blocked by cytochalasin and not by colchicine. One
can ask whether colchicine has an effect on the
production of filopodia since the depolymerization
of microtubules in megakaryocytes in short term
cultures which were exhibiting long cytoplasmic
processes triggered their retraction
as shown by
Radley and Haller (Blood 1982, (60)213).
Authors:
One can conclude that two seperate
mechanisms bring about flattening on the one hand,
and filopodia retraction
on the other. In this
series we did not look at the mechanisms as we did
not wish to add an additional variable which may
have influenced the fragmentation.
D.B. Warheit:
Can the authors confirm that the
fragmentation products indeed are platelets? Have
they looked for platelet granules using TEM?
Authors: Wehave been unable, as yet, to perform
TEM. We base our conclusions on the functional
and morphological behavior of the fragments when
compared to platelets from peripheral blood.
D.B. Warheit:
How do you reconcile internal
fragmentation with the figure 8?
Authors:
We believe that the photomicrograph
shows a megakaryocyte in the
process of
fragmenting, and that this process is taking place
whilst the general shape of the megakaryocyte is
still preserved. The time frame from this stage
until complete fragmentation is unknown, but is
probably a matter of minutes, as this event is
relatively a rare finding whilst fragmentation is
commonunder these circumstances.
D.B. Warheit:
What was the basis for using
glutaraldehyde-fixed ECMand what is the source of
the inhibitory effect on megakaryocyte adherence?
Authors: Wechose glutaraldehyde as one method of
denaturating the surface proteins of the ECM
thereby changing their secondary and tertiary
structure. This denaturation renders the adhesive
glycoproteins of the matrix non-sticky to cells.
0.8. Warheit:
Do the 25% of flattened cells
represent
a different
population
from the
fragmented cells?
Authors:
If
by "different"
you mean nonmegakaryocytes, the answer is no, because only
megakaryocytes were counted. It is possible that
these represented cells at a different stage of
development or
maturation
(nuclear
and/or
cytoplasmic). It is believed that only the most
mature megakaryocytes produce platelets. There was
no reason to assume that 100%of the cells would
be equally mature and react in an identical
manner.
D.B. Warheit:
Is this a relevant model to
platelet formation in-vivo?
Authors: As we have explained previously, we feel
that this is a relevant model. As the complete
mechanism and location of platelet formation has
not yet been proven,
confirming that these
fragments are indeed platelets
should help in
clarifying this point.
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K.M. Young: Are specific markers for endothelial
cells available so that bone marrow endothelium
could be isolated and evaluated in studies such as
these? It would seem particularly
relevant to
study endothelium from that tissue if it is
possible.
Authors: It is not possible at present, to the
best of our knowledge, to isolate bone marrow
endothelial cells for physical reasons such as
the smallness of the sinusoids and disruption upon
sampling, as well as the problems of overgrowth by
other cells in culture.
K. M. Young: The entry of megakaryocytes into
the vascular system as a routine phenomenon is
controversial.
Certainly, megakaryocyte cytoplasm
contacts the sinus wall and extends into the
sinus, but statements implying that the whole cell
enters the sinus should be avoided.
Authors: We would beg to differ on this point.
Manyauthors have described and discussed 1n
detail the presence of whole MK's in the venous
blood, in numbers approaching the
theoretical
figure for total platelet
production. Wedo not
feel that this is a controversial point, only the
fate of those cells.
Following papers, as well as many other
authors, have addressed this point.
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